Moderna
MRNA
159 hedge funds and large institutions have $3.41B invested in Moderna in 2019 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 68 increasing their positions, 34 reducing their positions, and 17 closing their positions.
144% more call options, than puts
Call options by funds: $24.3M | Put options by funds: $9.97M
141% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 17
100% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 34
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
27% more capital invested
Capital invested by funds: $2.68B → $3.41B (+$723M)
17% more funds holding
Funds holding: 136 → 159 (+23)
1.21% more ownership
Funds ownership: 51.06% → 52.27% (+1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$64.8M |
| 2 |
BlackRock
New York
|
+$59.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$57.8M |
| 4 |
SCM
Segantii Capital Management
Hong Kong
|
+$19.4M |
| 5 |
TP
Theleme Partners
London,
United Kingdom
|
+$14.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$141M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$24.1M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$15.6M |
| 4 |
RWA
Ropes Wealth Advisors
Boston,
Massachusetts
|
-$15.2M |
| 5 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
-$7.1M |
MRNA Hedge Fund Activity: Q4 2019 in Review
159 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q4 2019, worth a combined $3.41B — up 27% from $2.68B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new MRNA positions and 17 closed out — a net gain of 24 holders — while 68 added to existing stakes and 34 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $64.8M. The largest seller was Flagship Pioneering, cutting an estimated $141M.
- 159 institutional investors held Moderna (MRNA) as of Q4 2019, up from 136 in Q3 2019.
- Funds reported $3.41B of Moderna stock for Q4 2019, up 27% quarter-over-quarter.
- 41 funds opened new Moderna positions in Q4 2019 and 17 closed out, a net change of +24 holders.
- The largest Moderna buyer in Q4 2019 was Fidelity Investments, an estimated $64.8M added.
- The largest Moderna seller in Q4 2019 was Flagship Pioneering, an estimated $141M sold.
Based on aggregated 13F filings for Q4 2019.